Corrigendum to “Caspase 9 is constitutively activated in mouse oocytes and plays a key role in oocyte elimination during meiotic prophase progression” [Dev. Biol. Vol.377 (2013) 213-223] (Developmental Biology (2013) 377(213-223), (S0012160613000572), (10.1016/j.ydbio.2013.01.027));Caspase 9 is constitutively activated in mouse oocytes and plays a key role in oocyte elimination during meiotic prophase progression

Developmental Biology

Volumn 377, Issue 1, 2013, Pages 213-223

  Ene, Adriana C ^a   Park, Stephanie ^a   Edelmann, Winfried ^b   Taketo, Teruko ^a  

^a ROYAL VICTORIA HOSPITAL   (Canada)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

Apoptosis; Caspase 9; Msh5; Oocyte; PARP1

Indexed keywords

CASPASE 7; CASPASE 9; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE 1; X LINKED INHIBITOR OF APOPTOSIS;

ANIMAL CELL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL COUNT; CELL NUCLEUS; CONTROLLED STUDY; DNA REPAIR; DOUBLE STRANDED DNA BREAK; ENZYME ACTIVATION; ENZYME ACTIVITY; GENE; GENE SILENCING; GENOTYPE; IMMUNOBLOTTING; IMMUNOFLUORESCENCE; MEIOTIC PROPHASE I; MOUSE; MSH5 GENE; NONHUMAN; OOCYTE; OVARY; OVARY DEVELOPMENT; PRIORITY JOURNAL; PROTEIN CLEAVAGE; PROTEIN LOCALIZATION; WILD TYPE;

MAMMALIA;

EID: 84876308017     PISSN: 00121606     EISSN: 1095564X     Source Type: Journal    
DOI: 10.1016/j.ydbio.2020.08.001     Document Type: Erratum

References (47)

1. Alton M., Taketo T. Switch from BAX-dependent to BAX-independent germ cell loss during the development of fetal mouse ovaries. J. Cell Sci. 2007, 120:417-424.
2. Ashley T., Westphal C., De Maggio A.P., De Rooij D.G. The mammalian mid-pachytene checkpoint: meiotic arrest in spermatocytes with a mutation in Atm alone or in combination with a Trp53(P53) or Cdkn1a (P21/cip1) mutation. Cytogenet. Genome Res. 2004, 107:256-262.
3. Bailis J.M., Roeder G.S. Pachytene exit controlled by reversal of Mek1-dependent phosphorylation. Cell 2000, 101:211-221.
4. Baker T.G. A quantitative and cytological study of germ cells in human ovaries. Proc. R. Soc. London B 1963, 158:417-433.
5. Beaumont H.M., Mandl A.M. A quantitative and cytological study of oogonia and oocytes in the foetal and neonatal rat. Proc. R. Soc. London B 1962, 155:557-579.
6. Bergeron L., Perez G.I., Macdonald G., Shi L., Sun Y., Jurisicova A., Varmuza S., Latham K.E., Flaws J.A., Salter J.C.M., Hara H., Moskowitz M.A., Li E., Greenberg A., Tilly J.L., Yuan J. Defects in regulation of apoptosis in caspase-2-deficient mice. Genes Dev. 1998, 12:1304-1314.
7. Borum K. Oogenesis in the mouse. A study of the meiotic prophase. Exp. Cell Res. 1961, 24:495-507.
8. Cohen P.E., Pollack S.E., Pollard J.W. Genetic analysis of chromosome pairing, recombination, and cell cycle control during first meiotic prophase in mammals. Endocr. Rev. 2006, 27:398-426.
9. Conze D.B., Albert L., Ferrick D.A., Goeddel D.V., Yeh W.C., Mak T., Ashwell J.D. Posttranscriptional downregulation of c-IAP2 by the ubiquitin protein ligase c-IAP1 in vivo. Mol. Cell. Biol. 2005, 25:3348-3356.
10. De Felici M. Establishment of oocyte population in the fetal ovary: primordial germ cell proliferation and oocyte programmed cell death. RBM Online 2005, 10:182-191.
11. De Felici M., Lobascio A.M., Klinger F.G. Cell death in fetal oocytes. Autophagy 2008, 4:240-242.
12. De Vries S.S., Baart E.B., Dekker M., Siezen A., De Rooij D.G., De Boer P., Te Riele H. Mouse MutS-like protein Msh5 is required for proper chromosome synapsis in male and female meiosis. Genes Dev. 1999, 13:523-531.
13. Deveraux Q.L., Roy N., Stennicke H.R., van Arsdale T., Zhou Q., Srinivascula S.M., Alnemri E.S., Salvesen G.S., Reed J.C. IAPs block apoptotic events induced by caspase-8 and cytochrome c by direct inhibition of distinct caspases. Embo J. 1998, 17:2215-2223.
14. Deveraux Q.L., Takahashi R., Salvesen G.S., Reed J.C. X-linked IAP is a direct inhibitor of cell-death proteases. Nature 1997, 388:300-303.
15. Di Giacomo M., Barchi M., Baudat F., Edelmann W., Keeney S., Jasin M. Distinct DNA-damage-dependent and -independent responses drive the loss of oocytes in recombination-defective mouse mutants. Proc. Natl. Acad. Sci. USA 2005, 102:737-742.
16. Dietrich A.J.J., Mulder R.J.P. A light and electron microscopic analysis of meiotic prophase in female mice. Chromosoma 1983, 88:377-385.
17. Dobson M.J., Pearlman R.E., Karaiskakis A., Spyropoulos B., Moens P.B. Synaptonemal complex proteins: occurrence, epitope mapping and chromosome disjunction. J. Cell Sci. 1994, 107:2749-2760.
18. Edelmann W., Cohen P.E., Kneitz B., Winand N., Lia M., Heyer J., Kolodner R., Pollard J.W., Kucherlapati R. Mammalian Mut5 homologue 5 is required for chromosome pairing in meiosis. Nature Genet. 1999, 21:123-127.
19. Enders G.C., May J.J.I. Developmentally regulated expression of a mouse germ cell nuclear antigen examined from embryonic Day 11 to adult in male and female mice. Dev. Biol. 1994, 163:331-340.
20. Flaws J.A., Hirshfield A.N., Hewitt J.A., Babus J.K., Furth P.A. Effect of Bcl-2 on the primordial follicle endowment in the mouse ovary. Biol. Reprod. 2001, 64:1153-1159.
21. Ghafari F., Gutierrez C.G., Hartshorne G.M. Apoptosis in mouse fetal and neonatal oocytes during meiotic prophase one. BMC Dev. Biol. 2007, 7:87.
22. Hakem R., Hakem A., Duncan G.S., Henderson J.T., Woo M., Soengas M.S., Elia A., de la Pompa J.L., Kagi D., Khoo W., Potter J., Yoshida R., Kaufman S.A., Lowe S.W., Penninger J.M., Mak T.W. Differential requirement for caspase 9 in apoptotic pathways in vivo. Cell 1998, 94:339-352.
23. Harlin H., Reffey S.B., Duckett C.S., Lindsten T., Thompson C.B. Characterization of XIAP-deficient mice. Mol. Cell. Biol. 2001, 21:3604-3608.
24. Johnson C., Jia Y., Wang C., Lue Y.H., Swerdloff R.S., Zhang X.S., Hu Z.Y., Li Y.C., Liu Y.X., Hikim A.P.S. Role of caspase 2 in apoptotic signaling in primate and murine germ cells. Biol. Reprod. 2008, 79:806-814.
25. Kawamura K., Sato N., Fukuda J., Kodama H., Kumagai J., Tanikawa H., Shimizu Y., Tanaka T. Survivin acts as an antiapoptotic factor during the development of mouse preimplantation embryos. Dev. Biol. 2003, 256:331-341.
26. Kruidering M., Evan G.I. Caspase-8 in apoptosis: the beginning of 'the end'?. IUBMB Life 2000, 50:85-90.
27. Kuida K., Haydar T.F., Kuan C.Y., Gu Y., Taya C., Karasuyama H., Su M.S.S., Rakic P., Flavell R.A. Reduced apoptosis and cytochrome c-mediated caspase activation in mice lacking caspase 9. Cell 1998, 94:325-337.
28. Li J., Kim J.M., Liston P., Li M., Miyazaki T., Mackenzie A.E., Korneluk R.G., Tsang B.K. Expression of inhibitor of apoptosis proteins (IAPs) in rat granulosa cells during ovarian follicular development and atresia. Endocrinology 1998, 139:1321-1328.
29. Los M., Wesselborg S., Schulze-Osthoff K. The role of caspases in development, immunity, and apoptotic signal transduction: lessons from knockout mice. Immunity 1999, 10:629-639.
30. Matikainen T., Perez G.I., Zheng T.S., Kluzak T.R., Rueda B.R., Flavell R.A., Tilly J.L. Caspase-3 gene knockout defines cell lineage specificity for programmed cell death signaling in the ovary. Endocrinology 2001, 142:2468-2479.
31. McClellan K.A., Gosden R., Taketo T. Continuous loss of oocytes throughout meiotic prophase in the normal mouse ovary. Dev. Biol. 2003, 258:334-348.
32. Morita Y., Tilly J.L. Oocyte apoptosis: like sand through an hourglass. Dev. Biol. 1999, 213:1-17.
33. Pepling M.E., Spradling A.C. Mouse ovarian germ cell cysts undergo programmed breakdown to form primordial follicles. Dev. Biol. 2001, 234:339-351.
34. Perez G.I., Robles R., Knudson C.M., Flaws J.A., Korsmeyer S.J., Tilly J.L. Prolongation of ovarian lifespan into advanced chronological age by Bax-deficiency. Nat. Genet. 1999, 21:200-203.
35. Ratts V., Flaws J.A., Kolp R., Sorenson C.M., Tilly J.L. Ablation of bcl-2 gene expression decreases the numbers of oocytes and primordial follicles established in the post-natal female mouse gonad. Endocrinology 1995, 136:3665-3668.
36. Robertson J.D., Enoksson M., Suomela M., Zhivotovsky B., Orrenius S. Caspase-2 acts upstream of mitochondria to promote cytochrome c release during etoposide-induced apoptosis. J. Biol. Chem. 2002, 277:29803-29809.
37. Rodrigues P., Limback D., McGinnis L.K., Plancha C.E., Albertini D.F. Multiple mechanisms of germ cell loss in the perinatal mouse ovary. Reproduction 2009, 137:709-720.
38. Rucker E.B.I., Dierisseau P., Wagner K.U., Garrett L., Wynshaw-Boris A., Flaws J.A., Hennighausen L. Bcl-x and Bax regulate mouse primordial germ cell survival and apoptosis during embryogenesis. Mol. Endocrinol. 2000, 14:1038-1052.
39. Slee E.A., Harte M.T., Kluck R.M., Wolf B.B., Casiano C.A., Newmeyer D.D., Wang H.G., Reed J.C., Nicholson D.W., Alnemri E.S., Green D.R., Martin S.J. Ordering the cytochrome c-initiated caspase cascade: hierarchical activation of caspases-2, -3, -6, -7, -8, and -10 in a caspase-9-dependent manner. J. Cell Biol. 1999, 144:281-292.
40. Speed R.M. The possible role of meiotic pairing anomalies in the atresia of human fetal oocytes. Hum. Genet. 1988, 78:260-266.
41. Taketo T. Microspread oocyte preparations for the analysis of meiotic prophase progression with improved recovery by cytospin centrifugation. Methods Mol. Biol. 2012, 825:173-181.
42. Taketo T., Lee C.H., Zhang J., Li Y., Lee C.Y.G., Lau Y.F.C. Expression of SRY proteins in both normal and sex-reversed XY fetal mouse gonads. Dev. Dyn. 2005, 233:612-622.
43. Thress K., Kornbluth S., Smith J.J. Mitochondria at the crossroad of apoptotic cell death. J. Bioenerg. Biomembr. 1999, 31:321-326.
44. Tilly J.L. Commuting the death sentence: how oocytes strive to survive. Nat. Rev. Mol. Cell Biol. 2001, 2:838-848.
45. Toyooka Y., Tsunekawa N., Takahashi Y., Matsui Y., Satoh M., Noce T. Expression and intracellular localization of mouse Vasa-homologue protein during germ cell development. Mech. Dev. 2000, 93:139-149.
46. Vaux D.L., Silke J. IAPs-the ubiquitin connection. Cell Death Differ. 2005, 12:1205-1207.
47. Viswanath V., Wu Y., Boonplueang R., Chen S., Stevenson F.F., Yantiri F., Yang L., Flint B.M., Andersen J.K. Caspase-9 activation results in downstream caspase-8 activation and bid cleavage in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinson's disease. J. Neurosci. 2001, 21:9519-9528.